Bristol Myers' (BMY) application seeking approval for the Opdivo/Yervoy combo to treat unresectable hepatocellular carcinoma gets accepted for FDA...

FRIDAY, Aug. 16, 2024 -- For patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does...

THURSDAY, Aug. 22, 2024 -- Patients treated with neoadjuvant immune checkpoint inhibitor (ICI)-based therapy for hepatocellular carcinoma (HCC) have...

BRISBANE, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing...

Liver disease is a common condition affecting millions of adults in the United States. One serious form of this disease is nonalcoholic fatty liver...

PYC starts human trials for PYC-001 to treat rare eye disease. OncoSil device successfully treats first patient in Türkiye ...

Chronic liver disease is a serious condition that affects the liver over a long period, often leading to life-threatening complications. The liver is...

Cancer doesn’t grow in a vacuum – each tumour grows in a particular microenvironment within the body and spreads through a tangled web of...

This rising “It” drug looks like designer chocolate, is micro-dosed among the monied set – and is illegal.

This rising “It” drug looks like designer chocolate, is micro-dosed among the monied set – and is illegal.